Ross is a partner in the Corporate Technology & Life Sciences team, based in our Cambridge office.

Ross is a lead partner within the firm's Tier 1-ranked Biotechnology practice in Cambridge. His practice involves helping life sciences and technology companies as they progress through their life cycle in all aspects of their growth, capital raising and international expansion. As a sector specialist, Ross focuses on biotech, medical devices and diagnostics within Life Sciences, and with the Tech sector supports companies operating in the capital intensive deep tech space, including quantum computing, artificial intelligence, advanced materials, as well as web3.

Ross has extensive experience of a variety of venture and growth financing, public capital raisings, mergers and acquisitions and general corporate advice. Ross was based out of San Francisco, CA in 2018 – 19 and as a result, he has a particular expertise in transactions with a transatlantic component.

CV ansehen CV ausblenden

Aktuelle News & Insights

Gesellschaftsrecht/ M&A & Kapitalmärkte

Advising Lingotto-led investors on chip developer Optalysys Series A funding

24. Juli 2023

von mehreren Autoren

Klicken Sie hier für Details

Advising BITKRAFT Ventures on its investment in Scriptic

3. Juli 2023

von Richard Faichney und Ross McNaughton

Klicken Sie hier für Details
Life Sciences & Healthcare

Word on the street at the J.P. Morgan Healthcare Conference 2023

1. Februar 2023

von mehreren Autoren

Klicken Sie hier für Details

Ross McNaughton recognised in The Lawyer's 2023 Hot 100

23. Januar 2023

von Ross McNaughton

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.